In the keto and non-keto groups, respectively:
responses to CsA were 73.0% and 55.1% for complete remission, (p=0.213), and 10% and 3% for partial remission, (p=0.645);
resistance was 19.8% and 38.8%, (p=0.029);
the mean (+/- standard deviation) durations of CsA treatment were 23.72 (+/- 12.22) months and 19.31 (+/- 11.78) months, (p=0.845);
responses to CsA discontinuation were 16.1% and 10.2%, (p=0.452) for relapse, 6.6% and 2.0%, (p=0.762) for maintained remission, and 16.8% and 32.7%, (p=0.408) for maintained relapse;
steroid discontinuation was 56.9% and 38.8% in steroid-dependent individuals, and 43.1% and 61.2% in steroid-resistant individuals, (p=0.022);
initial serum creatinine levels were 0.58 (+/- 0.18) versus 0.54 (+/- 0.18) mg/dL, (p=0.273);
serum creatinine at last follow-up was 0.67 (+/- 0.48) versus 0.79 (+/- 0.54) mg/dL, (p=0.009);
initial creatinine clearance was 125.20 (+/- 9.39) versus 127.00 (+/- 9.19) mL/minute per 1.73 m2, (p=0.246);
creatinine clearance at last follow-up was 120.56 (+/- 18.69) versus 108.34 (+/- 33.54) mL/minute per 1.73 m2, (p<0.001);
initial 24-hour urinary protein excretion was 6.33 (+/- 2.61) versus 6.71 (+/- 2.85) g, (p=0.500); and
24-hour urinary protein excretion at last follow-up was 1.05 (+/- 2.01) versus 1.98 (+/- 2.98) g, (p<0.001).
the frequency of hypertension was 11.7% versus 24.5%, (p=0.060);
the frequency of renal dysfunction was 3.6% versus 20.4%, (p=0.003);
the frequency of gingival hyperplasia was 29.2% versus 18.7%, (p=0.269); and
the frequency of hirsutism was 56.2% versus 42.9%, (p=0.212).